Literature DB >> 26628595

Coronary, Carotid, and Lower-extremity Atherosclerosis and Their Interrelationship in Danish Patients with Systemic Lupus Erythematosus.

Susan Due Kay1, Mikael Kjaer Poulsen2, Axel Cosmus Pyndt Diederichsen2, Anne Voss2.   

Abstract

OBJECTIVE: Atherosclerosis is highly prevalent among patients with systemic lupus erythematosus (SLE), but has been demonstrated predominantly in non-European SLE cohorts and few investigations have included more than 1 imaging modality. We aimed to investigate the prevalence of atherosclerosis in 3 frequently affected vascular territories, the coronary, carotid, and lower-extremity arteries, in a Danish, predominantly population-based SLE cohort.
METHODS: Patients with SLE without prior cardiovascular disease (CVD; n = 103) were screened for coronary artery calcification, carotid intima-media thickening and plaque, and abnormal ankle-brachial index by means of cardiac computed tomography, ultrasound of the carotid arteries, and ankle systolic blood pressure.
RESULTS: In patients with SLE, the prevalence of atherosclerosis in any vascular territory was 41%. The distribution of the atherosclerotic manifestations showed an overlap with 45% of the patients having involvement in more than 1 vascular territory. However, more than one-third of the patients with SLE with coronary, carotid, or lower-extremity atherosclerosis exclusively demonstrated this particular manifestation. Based on a multiple logistic regression model, age (p < 0.001), current smoking (p = 0.009), and the Systemic Lupus International Collaborating Clinics (SLICC; p = 0.008) were significant independent risk factors for atherosclerosis at any vascular territory.
CONCLUSION: Atherosclerosis is highly prevalent among Danish patients with SLE without prior CVD. Screening for atherosclerosis in 1 vascular territory is insufficient in diagnosing atherosclerosis in patients with SLE. In Danish patients with SLE, the presence of atherosclerosis was not only assigned to traditional CV risk factors, but also associated with SLICC.

Entities:  

Keywords:  ANKLE BRACHIAL INDEX; ATHEROSCLEROSIS; CAROTID INTIMA-MEDIA THICKNESS; CAROTID PLAQUE; CORONARY ARTERY CALCIUM; SYSTEMIC LUPUS ERYTHEMATOSUS

Mesh:

Year:  2015        PMID: 26628595     DOI: 10.3899/jrheum.150488

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  10 in total

1.  Arterial stiffness and peripheral arterial disease in patients with systemic lupus erythematosus.

Authors:  Konstantinos Tziomalos; Ioannis Gkougkourelas; Alexandros Sarantopoulos; Eleni Bekiari; Evangelia Makri; Nikolaos Raptis; Konstantinos Tselios; Marianna Pantoura; Apostolos I Hatzitolios; Panagiota Boura
Journal:  Rheumatol Int       Date:  2016-11-21       Impact factor: 2.631

2.  IL-17A levels in systemic lupus erythematosus associated with inflammatory markers and lower rates of malignancy and heart damage: Evidence for a dual role.

Authors:  Warren Raymond; Gro Ostli-Eilertsen; Sheynae Griffiths; Johannes Nossent
Journal:  Eur J Rheumatol       Date:  2017-03-01

Review 3.  Psoriasis as a human model of disease to study inflammatory atherogenesis.

Authors:  Charlotte L Harrington; Amit K Dey; Raza Yunus; Aditya A Joshi; Nehal N Mehta
Journal:  Am J Physiol Heart Circ Physiol       Date:  2017-03-03       Impact factor: 4.733

Review 4.  Cardiovascular disease in systemic lupus erythematosus.

Authors:  Maureen McMahon; Richard Seto; Brian J Skaggs
Journal:  Rheumatol Immunol Res       Date:  2021-12-15

5.  GlycA Is a Novel Biomarker of Inflammation and Subclinical Cardiovascular Disease in Psoriasis.

Authors:  Aditya A Joshi; Joseph B Lerman; Tsion M Aberra; Mehdi Afshar; Heather L Teague; Justin A Rodante; Parasuram Krishnamoorthy; Qimin Ng; Tarek Z Aridi; Taufiq Salahuddin; Balaji Natarajan; Benjamin N Lockshin; Mark A Ahlman; Marcus Y Chen; Daniel J Rader; Muredach P Reilly; Alan T Remaley; David A Bluemke; Martin P Playford; Joel M Gelfand; Nehal N Mehta
Journal:  Circ Res       Date:  2016-09-21       Impact factor: 17.367

Review 6.  Misunderstandings Between Platelets and Neutrophils Build in Chronic Inflammation.

Authors:  Giuseppe A Ramirez; Angelo A Manfredi; Norma Maugeri
Journal:  Front Immunol       Date:  2019-10-22       Impact factor: 7.561

7.  Assessment of subclinical atherosclerosis with ankle-brachial index in psoriatic arthritis: A case-control study.

Authors:  Serhad Bilim; Afitap Içağasioğlu; Ayla Akbal; Esen Kasapoğlu; Sıdıka Gürsel
Journal:  Arch Rheumatol       Date:  2021-01-14       Impact factor: 1.472

8.  Effects of tobacco smoking on cardiovascular disease in patients with systemic lupus erythematosus: A systematic review and meta-analysis.

Authors:  Wan-Tong Zhang; Zhao Liu; Bao-Chen Zhu; Zi-Yang Cui; Cheng Huang; Xu-Jie Wang; Fang Lu; Qiu-Yan Li; Wei-Liang Weng; Guo-Dong Hua; Chun-Miao Xue
Journal:  Front Immunol       Date:  2022-07-27       Impact factor: 8.786

Review 9.  Management of lupus nephritis: a systematic literature review informing the 2019 update of the joint EULAR and European Renal Association-European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations.

Authors:  Myrto Kostopoulou; Antonis Fanouriakis; Kim Cheema; John Boletis; George Bertsias; David Jayne; Dimitrios T Boumpas
Journal:  RMD Open       Date:  2020-07

Review 10.  GlycA measured by NMR spectroscopy is associated with disease activity and cardiovascular disease risk in chronic inflammatory diseases.

Authors:  Nehal N Mehta; Amit K Dey; Reethika Maddineni; William E Kraus; Kim M Huffman
Journal:  Am J Prev Cardiol       Date:  2020-11-07
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.